BRIEF-UK's CMA says not refer Mckesson unit, AAH Pharma-UDG deal for phase 2 probe
June 29, 2016 at 10:27 AM EDT
* UK's CMA says decided not to refer merger by Mckesson Corp unit AAH Pharmaceuticals of MASTA and Sangers to a Phase 2 investigation. Source text for Eikon: (http://bit.ly/29eSv3J) (Bengaluru Newsroom)
